Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Evolent Health- Inc. (EVH)

24.1 0.4 (1.69%)

08-20 16:02

Open:

24

Pre. Close:

23.7

High:

24.3

Low:

23.3

Volume:

794,990

Market Cap:

1895M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

24.035 - 24.156

24.156 - 24.256

Low:

23.072 - 23.199

23.199 - 23.304

Close:

23.512 - 23.713

23.713 - 23.878

Technical analysis  (as of: 2018-08-20 3:20:50 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 28.32     One year: 33.08

Support:

Support1: 21.25    Support2: 19.40

Resistance:

Resistance1: 24.25    Resistance2: 28.32

Pivot:

21.92

Moving Averages:

MA(5): 23.84     MA(20): 21.75

MA(100): 20.01     MA(250): 16.85

MACD:

MACD(12,26): 0.52     Signal(12,26,9): 0.16

%K %D:

%K(14,3): 94.59     %D(3): 92.78

RSI:

RSI(14): 62.86

52-Week:

High: 24.3  Low: 13.055  Change(%): 40.0

Average Vol(K):

3-Month: 89283  10-Days 89314

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EVH has closed below upper band by 15.4%. Bollinger Bands are 97.3% wider than normal. The large width of the bands suggest high volatility as compared to EVH's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

2018-08-11T18:30:40-04:00
Evolent Health (EVH) CEO Frank Williams on Q2 2018 Results - Earnings Call Transcript

2018-08-07T16:32:16-04:00
Evolent Health beats by $0.01, beats on revenue

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Technology

Industry:  Health Information Services

Shares Out. (M)

78.65

Shares Float (M)

76.73

% Held by Insiders

2.50

% Held by Institutions

Shares Short (K)

8943

Shares Short Prior Month (K)

Stock Financials

EPS

-0.250

EPS Est. Current Year

-0.400

EPS Est. Next Year

-0.010

EPS Est. Next Quarter

-0.050

Forward EPS

1.#IO

Book Value (p.s.)

1.810

PEG Ratio

-8.89

Profit Margin

-10.09

Operating Margin

-8.72

Return on Assets (ttm)

-4.0

Return on Equity (ttm)

-5.2

Qtrly Rev. Growth

34.8

Gross Profit (p.s.)

0.504

Sales Per Share

EBITDA (p.s.)

-0.079

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.15

Levered Free Cash Flow (M)

Valuation

P/E

-96.30

P/E Growth Ratio

0.02

P/BV

13.30

P/S

276135648.00

P/CF

-232.32

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.